| Persistent COVID-19 symptoms in a community study of 606,434 people in England M Whitaker, J Elliott, M Chadeau-Hyam, S Riley, A Darzi, G Cooke, ... Nature communications 13 (1), 1-10, 2022 | 387* | 2022 |
| SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ... Nature communications 12 (1), 905, 2021 | 192 | 2021 |
| Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data M Chadeau-Hyam, B Bodinier, J Elliott, MD Whitaker, I Tzoulaki, ... International journal of epidemiology 49 (5), 1454-1467, 2020 | 144 | 2020 |
| Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults H Ward, G Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ... MedRxiv, 2020.10. 26.20219725, 2020 | 142 | 2020 |
| The history of 3D printing in healthcare M Whitaker The Bulletin of the Royal College of Surgeons of England 96 (7), 228-229, 2014 | 139 | 2014 |
| Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults H Ward, CJ Atchison, M Whitaker, KEC Ainslie, J Elliott, LC Okell, R Redd, ... | 136 | 2020 |
| COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors J Elliott, B Bodinier, M Whitaker, C Delpierre, R Vermeulen, I Tzoulaki, ... European journal of epidemiology 36, 299-309, 2021 | 129 | 2021 |
| Rapid increase in Omicron infections in England during December 2021: REACT-1 study P Elliott, B Bodinier, O Eales, H Wang, D Haw, J Elliott, M Whitaker, ... Science 375 (6587), 1406-1411, 2022 | 125 | 2022 |
| Population antibody responses following COVID-19 vaccination in 212,102 individuals H Ward, M Whitaker, B Flower, SN Tang, C Atchison, A Darzi, ... Nature communications 13 (1), 907, 2022 | 124 | 2022 |
| Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England M Whitaker, J Elliott, B Bodinier, W Barclay, H Ward, G Cooke, ... Nature Communications 13 (1), 6856, 2022 | 108* | 2022 |
| Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people J Elliott, M Whitaker, B Bodinier, O Eales, S Riley, H Ward, G Cooke, ... PLoS medicine 18 (9), e1003777, 2021 | 95 | 2021 |
| Twin peaks: the Omicron SARS-CoV-2 BA. 1 and BA. 2 epidemics in England P Elliott, O Eales, N Steyn, D Tang, B Bodinier, H Wang, J Elliott, ... Science 376 (6600), eabq4411, 2022 | 87 | 2022 |
| Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults H Ward, GS Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ... The Lancet Regional Health–Europe 4, 2021 | 83 | 2021 |
| Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ... MedRxiv, 2020.08. 12.20173690, 2020 | 83 | 2020 |
| Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study SJ Bowden, B Bodinier, I Kalliala, V Zuber, D Vuckovic, T Doulgeraki, ... The Lancet Oncology 22 (4), 548-557, 2021 | 70 | 2021 |
| The surgical personality: does it exist? M Whitaker The Annals of The Royal College of Surgeons of England 100 (1), 72-77, 2017 | 61 | 2017 |
| REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England H Ward, G Cooke, M Whitaker, R Redd, O Eales, JC Brown, K Collet, ... MedRxiv, 2021.02. 26.21252512, 2021 | 48 | 2021 |
| SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys M Chadeau-Hyam, H Wang, O Eales, D Haw, B Bodinier, M Whitaker, ... The Lancet Respiratory Medicine 10 (4), 355-366, 2022 | 45 | 2022 |
| Education, biological ageing, all-cause and cause-specific mortality and morbidity: UK biobank cohort study M Chadeau-Hyam, B Bodinier, R Vermeulen, M Karimi, V Zuber, ... EClinicalMedicine 29, 2020 | 33 | 2020 |
| Prospective identification of elevated circulating CDCP1 in patients years before onset of lung cancer S Dagnino, B Bodinier, F Guida, K Smith-Byrne, D Petrovic, MD Whitaker, ... Cancer research 81 (13), 3738-3748, 2021 | 28 | 2021 |
Paul ElliottProfessor of Epidemiology and Public Health, Imperial College London在 imperial.ac.uk 的电子邮件经过验证
